Molecular Oncology Almanac
API
Approvals
Organizations
About
Contact
Follicular Lymphoma
About
Mappings
OncoTree
:
Follicular Lymphoma (oncotree:FL)
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
Type
Biomarker(s)
Cancer type
Therapy(ies)
Sensitivity (+)
EZH2 p.Y646N
Follicular Lymphoma
Tazemetostat
Sensitivity (+)
EZH2 p.Y646F
Follicular Lymphoma
Tazemetostat
Sensitivity (+)
EZH2 p.Y646H
Follicular Lymphoma
Tazemetostat
Sensitivity (+)
EZH2 p.Y646S
Follicular Lymphoma
Tazemetostat
Sensitivity (+)
EZH2 p.Y646C
Follicular Lymphoma
Tazemetostat
Sensitivity (+)
EZH2 p.A862G
Follicular Lymphoma
Tazemetostat
Sensitivity (+)
EZH2 p.A692V
Follicular Lymphoma
Tazemetostat
Sensitivity (+)
CD20 +
Follicular Lymphoma
Cyclophosphamide
,
Prednisolone
,
Rituximab
,
Vincristine
Sensitivity (+)
CD20 +
Follicular Lymphoma
Cyclophosphamide
,
Doxorubicin
,
Prednisolone
,
Rituximab
,
Vincristine
Sensitivity (+)
CD20 +
Follicular Lymphoma
Chlorambucil
,
Mitoxantrone
,
Prednisolone
,
Rituximab
Sensitivity (+)
CD20 +
Follicular Lymphoma
Cyclophosphamide
,
Doxorubicin
,
Etoposide
,
Interferon Alpha
,
Prednisolone
,
Rituximab
Sensitivity (+)
CD20 +
Follicular Lymphoma
Rituximab
Sensitivity (+)
CD20 +
Follicular Lymphoma
Rituximab
Sensitivity (+)
CD20 +
Follicular Lymphoma
Rituximab
Sensitivity (+)
CD20 +
Follicular Lymphoma
Rituximab